Methods of treating pancreatic cancer using coenzyme q10
AssigneeBerg LLC
InventorsRangaprasad Sarangarajan, Niven Rajin Narain
Life of this patent
Estimating the term…
Abstract
The disclosure provides methods of treating pancreatic cancer in a population of subjects comprising administration of Coenzyme Q10. Administration of Coenzyme Q10 to the subjects increases the number of subjects in the population that exhibit stable disease. In addition, administration of Coenzyme Q10 to the subjects increases progression free survival, overall survival, and time to progression in the population of pancreatic cancer patients.
Claims25
A method of treating pancreatic cancer in a population of subjects in need thereof, the method comprising administering to each subject of the population a composition comprising Coenzyme Q10, wherein at least 10%, 20%, 30%, 40%, 50% or 53% of the subjects in the population exhibit stable disease as a result of administration of the Coenzyme Q10 to the subjects, thereby treating the pancreatic cancer in the population of subjects.
A method of treating pancreatic cancer in a population of subjects in need thereof, the method comprising administering to each subject of the population a composition comprising Coenzyme Q10, wherein the population of subjects exhibits a median progression free survival of at least 50, 60, 70, 80, 90, 100, 110, or 118 days as a result of administration of the Coenzyme Q10 to the subjects, thereby treating the pancreatic cancer in the population of subjects.
A method of treating pancreatic cancer in a population of subjects in need thereof, the method comprising administering to each subject of the population a composition comprising Coenzyme Q10, wherein the population of subjects exhibits a median overall survival of at least 50, 60, 70, 80, 90, 100, 110, 120, 125, 150, 175, 200 or 218 days as a result of administration of the Coenzyme Q10 to the subjects, thereby treating the pancreatic cancer in the population of subjects.
A method of treating pancreatic cancer in a population of subjects in need thereof, the method comprising administering to each subject of the population a composition comprising Coenzyme Q10, wherein the population of subjects exhibits a median time to progression of at least 10, 20, 30, 40, 50, 60, 65, 68, 70, 80, 90, 100, 110, 120 or 121 days as a result of administration of the Coenzyme Q10 to the subjects, thereby treating the pancreatic cancer in the population of subjects.
Dependencies are inferred from the claim text.